FDA Grants Pfizer’s Bivalent COVID-19 Vaccine Emergency Approval As Booster In Children Aged Six Months To Four Years

Bloomberg (3/14, Cattan) reports Pfizer’s “bivalent shot for Covid-19 has received emergency approval to be used as a booster in some infants and toddlers.” Kids “between six months and four years old can receive the Pfizer-BioNTech SE shot at least two m...